2020 Q1 Form 10-Q Financial Statement

#000082241620000014 Filed on April 23, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $2.295B $1.997B
YoY Change 14.94% 1.35%
Cost Of Revenue $1.745B $1.526B
YoY Change 14.32% 1.5%
Gross Profit $550.2M $470.4M
YoY Change 16.96% 0.86%
Gross Profit Margin 23.97% 23.56%
Selling, General & Admin $263.7M $252.7M
YoY Change 4.33% 4.91%
% of Gross Profit 47.92% 53.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $15.10M $13.20M
YoY Change 14.39% 10.92%
% of Gross Profit 2.74% 2.81%
Operating Expenses $263.7M $252.7M
YoY Change 4.33% 4.91%
Operating Profit $286.5M $217.7M
YoY Change 31.63% -3.47%
Interest Expense $3.600M $4.800M
YoY Change -25.0% 242.86%
% of Operating Profit 1.26% 2.21%
Other Income/Expense, Net -$2.524M -$973.0K
YoY Change 159.4% -25.61%
Pretax Income $263.8M $216.7M
YoY Change 21.72% -3.34%
Income Tax $60.06M $49.95M
% Of Pretax Income 22.77% 23.05%
Net Earnings $203.7M $166.8M
YoY Change 22.16% -2.34%
Net Earnings / Revenue 8.88% 8.35%
Basic Earnings Per Share $0.75 $0.59
Diluted Earnings Per Share $0.74 $0.59
COMMON SHARES
Basic Shares Outstanding 270.0M shares 277.6M shares
Diluted Shares Outstanding 271.2M shares 278.6M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.817B $1.055B
YoY Change 72.23% 598.68%
Cash & Equivalents $1.817B $1.055B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $7.858B $7.507B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.675B $8.562B
YoY Change 13.0% 12.42%
LONG-TERM ASSETS
Property, Plant & Equipment $76.00M $73.00M
YoY Change 4.11%
Goodwill
YoY Change
Intangibles $178.6M $123.7M
YoY Change 44.29% -10.03%
Long-Term Investments $54.50M $55.73M
YoY Change -2.21% -14.02%
Other Assets $216.0M $316.0M
YoY Change -31.65% -55.99%
Total Long-Term Assets $1.748B $1.645B
YoY Change 6.26% -21.29%
TOTAL ASSETS
Total Short-Term Assets $9.675B $8.562B
Total Long-Term Assets $1.748B $1.645B
Total Assets $11.42B $10.21B
YoY Change 11.91% 5.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $430.0M $444.0M
YoY Change -3.15% -0.45%
Accrued Expenses $1.304B $1.265B
YoY Change 3.08% 3.35%
Deferred Revenue
YoY Change
Short-Term Debt $270.0M $222.0M
YoY Change 21.62% -10.12%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.422B $2.244B
YoY Change 7.93% -4.18%
LONG-TERM LIABILITIES
Long-Term Debt $3.456B $3.024B
YoY Change 14.29% -2.07%
Other Long-Term Liabilities $16.00M $5.000M
YoY Change 220.0% 66.67%
Total Long-Term Liabilities $3.472B $3.029B
YoY Change 14.63% -2.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.422B $2.244B
Total Long-Term Liabilities $3.472B $3.029B
Total Liabilities $5.893B $5.274B
YoY Change 11.74% -2.91%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.530B $4.933B
YoY Change
Total Liabilities & Shareholders Equity $11.42B $10.21B
YoY Change 11.91% 5.16%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $203.7M $166.8M
YoY Change 22.16% -2.34%
Depreciation, Depletion And Amortization $15.10M $13.20M
YoY Change 14.39% 10.92%
Cash From Operating Activities $204.6M $158.9M
YoY Change 28.77% -5.98%
INVESTING ACTIVITIES
Capital Expenditures $20.14M $16.07M
YoY Change 25.32% 4.16%
Acquisitions $83.20M $0.00
YoY Change
Other Investing Activities -$1.706M -$291.0K
YoY Change 486.25% -35.62%
Cash From Investing Activities -$95.80M -$17.07M
YoY Change 461.26% 6.84%
FINANCING ACTIVITIES
Cash Dividend Paid $32.74M $30.80M
YoY Change 6.29% 16.91%
Common Stock Issuance & Retirement, Net $95.63M $23.55M
YoY Change 305.99% -58.51%
Debt Paid & Issued, Net $9.245M $3.605M
YoY Change 156.45% 699.33%
Cash From Financing Activities $491.0M -$194.6M
YoY Change -352.32% -29.09%
NET CHANGE
Cash From Operating Activities $204.6M $158.9M
Cash From Investing Activities -$95.80M -$17.07M
Cash From Financing Activities $491.0M -$194.6M
Net Change In Cash $599.8M -$52.75M
YoY Change -1237.12% -56.54%
FREE CASH FLOW
Cash From Operating Activities $204.6M $158.9M
Capital Expenditures $20.14M $16.07M
Free Cash Flow $184.5M $142.8M
YoY Change 29.15% -7.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MI
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-2766606
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3350 Peachtree Road NE, Suite 150
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta,
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30326
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
1-9804
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000822416
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
PULTEGROUP INC/MI/
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
25200000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
2700000000 USD
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2200000 USD
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei City Area Code
CityAreaCode
404
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
978-6400
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
268148512 shares
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1816778000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1217913000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34475000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
33543000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1851253000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
252727000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1251456000 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20190000 USD
CY2019Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7857664000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7680614000 USD
CY2020Q1 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
31636000 USD
CY2019Q4 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
24009000 USD
CY2020Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
363854000 USD
CY2019Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
508967000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
54495000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
59766000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
935532000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
895686000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
178553000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
124992000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
150387000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
170107000 USD
CY2020Q1 us-gaap Assets
Assets
11423374000 USD
CY2019Q4 us-gaap Assets
Assets
10715597000 USD
CY2020Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
429724000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
435916000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
344973000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
294427000 USD
CY2020Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1319808000 USD
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1399368000 USD
CY2020Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
72546000 USD
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
36093000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
270000000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
326573000 USD
CY2020Q1 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
700000000 USD
CY2019Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 USD
CY2020Q1 us-gaap Notes Payable
NotesPayable
2755932000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
2765040000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
5892983000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
5257417000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5530391000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5458180000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11423374000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10715597000 USD
CY2020Q1 us-gaap Revenues
Revenues
2294980000 USD
CY2019Q1 us-gaap Revenues
Revenues
1996693000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
263669000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2524000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-973000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
263769000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
216703000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60058000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49946000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
270000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
277637000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1218000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1003000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271218000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278640000 shares
CY2020Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
25000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
25000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
203736000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
166782000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5458180000 USD
CY2020Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
-735000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4095000 USD
CY2020Q1 us-gaap Dividends
Dividends
32609000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
95676000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14838000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8187000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5530391000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
4817782000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1445000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5800000 USD
CY2019Q1 us-gaap Dividends
Dividends
30831000 USD
CY2019Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24999000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10350000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7810000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
4933439000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
19955000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24690000 USD
CY2020Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
9729000 USD
CY2019Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
2979000 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20190000 USD
CY2019Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15149000 USD
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13210000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11479000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9019000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
903000 USD
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
39000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
189364000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
259865000 USD
CY2020Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-145113000 USD
CY2019Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-134217000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3534000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-64533000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26910000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3404000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
204615000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
158905000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20139000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16070000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
5837000 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1289000 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
83200000 USD
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1706000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-291000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7680614000 USD
CY2019Q4 us-gaap Assets
Assets
10715597000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95796000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17068000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9245000 USD
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3605000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
700000000 USD
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-56573000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-126273000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1445000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
95676000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24999000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14838000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10350000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
32740000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
30802000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
490978000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-194584000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
599797000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52747000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1251456000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1133700000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1851253000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1080953000 USD
CY2020Q1 phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
14019000 USD
CY2019Q1 phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
17164000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5540000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-30850000 USD
CY2019Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
2899016000 USD
CY2020Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
4332000 USD
CY2019Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
2917000 USD
CY2020Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
4132273000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4557000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3450000 USD
CY2020Q1 us-gaap Interest Income Other
InterestIncomeOther
3807000 USD
CY2019Q1 us-gaap Interest Income Other
InterestIncomeOther
4949000 USD
CY2020Q1 us-gaap Interest Expense Other
InterestExpenseOther
797000 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2019Q1 us-gaap Interest Expense Other
InterestExpenseOther
144000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
567000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
37000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2788000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
552000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2524000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-973000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
345000000.0 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
294400000 USD
CY2020Q1 phm Contractassetinsurancerenewals
Contractassetinsurancerenewals
35000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2020Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
273000 USD
CY2019Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
308000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1537000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1410000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
201901000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
165039000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1537000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1410000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1530000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1407000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
201908000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
165042000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
270000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
277637000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1218000 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1003000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
271218000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278640000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2020Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
363900000 USD
CY2019Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
509000000.0 USD
CY2020Q1 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
351200000 USD
CY2019Q4 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
494100000 USD
CY2020Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
2200000 USD
CY2019Q1 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-1100000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
30900000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
24000000.0 USD
CY2019Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
4347107000 USD
CY2020Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
449112000 USD
CY2019Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
9530000 USD
CY2020Q1 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
18449000 USD
CY2019Q1 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
17396000 USD
CY2020Q1 us-gaap Maximum Length Of Time Hedged In Cash Flow Hedge1
MaximumLengthOfTimeHedgedInCashFlowHedge1
P60D
CY2020Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
17643000 USD
CY2020Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
15961000 USD
CY2019Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
1805000 USD
CY2020Q1 phm Assets In Scope Under Accounting Standards Codification326
AssetsInScopeUnderAccountingStandardsCodification326
227100000 USD
CY2020Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
3276279000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
42000000.0 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
170100000 USD
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
434491000 USD
CY2020Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7857664000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7680614000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
210383000 USD
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
227495000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
39913000 USD
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
42381000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
36871000 USD
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
34563000 USD
CY2020Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
213425000 USD
CY2019Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
235313000 USD
CY2020Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
303582000 USD
CY2020Q1 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
3331103000 USD
CY2019Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
299437000 USD
CY2019Q4 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
3221962000 USD
CY2019Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
2917000 USD
CY2020Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
9729000 USD
CY2019Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
2979000 USD
CY2020Q1 us-gaap Assets
Assets
11423374000 USD
CY2020Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
5386000 USD
CY2019Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 USD
CY2020Q1 phm Net Realizable Value Adjustments Land Held For Sale Total
NetRealizableValueAdjustmentsLandHeldForSaleTotal
11000 USD
CY2019Q1 phm Net Realizable Value Adjustments Land Held For Sale Total
NetRealizableValueAdjustmentsLandHeldForSaleTotal
62000 USD
CY2020Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
4332000 USD
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6 segment
CY2020Q1 us-gaap Revenues
Revenues
2294980000 USD
CY2019Q1 us-gaap Revenues
Revenues
1996693000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
263769000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
216703000 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20200000 USD
CY2020Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
9729000 USD
CY2019Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
2979000 USD
CY2020Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
3276279000 USD
CY2020Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
4132273000 USD
CY2020Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
449112000 USD
CY2020Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7857664000 USD
CY2019Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
2899016000 USD
CY2019Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
4347107000 USD
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
434491000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14158000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
14295000 USD
CY2020Q1 us-gaap Senior Notes
SeniorNotes
2711796000 USD
CY2019Q4 us-gaap Senior Notes
SeniorNotes
2711659000 USD
CY2020Q1 us-gaap Other Notes Payable
OtherNotesPayable
44136000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
53381000 USD
CY2020Q1 us-gaap Notes Payable
NotesPayable
2755932000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
2765040000 USD
CY2020Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2797273000 USD
CY2019Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
3152046000 USD
CY2020Q1 us-gaap Other Notes Payable
OtherNotesPayable
44100000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
53400000 USD
CY2020Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y
CY2020Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
1000000000.0 USD
CY2020Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1500000000 USD
CY2020Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
256100000 USD
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
262800000 USD
CY2020Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
43900000 USD
CY2019Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
737200000 USD
CY2020Q1 us-gaap Dividends
Dividends
32600000 USD
CY2019Q1 us-gaap Dividends
Dividends
30800000 USD
CY2019Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000.0 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
150400000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
40300000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
6700000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
6500000 USD
CY2020Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
23600000 USD
CY2020Q1 us-gaap Other Notes Payable
OtherNotesPayable
44136000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
53381000 USD
CY2020Q1 us-gaap Senior Notes
SeniorNotes
2700000000 USD
CY2020Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
25200000 USD
CY2020Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
256100000 USD
CY2020Q1 phm Surety Bonds Outstanding
SuretyBondsOutstanding
1400000000 USD
CY2019Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
262800000 USD
CY2019Q4 phm Surety Bonds Outstanding
SuretyBondsOutstanding
1400000000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
15039000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
12262000 USD
CY2018Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
737013000 USD
CY2020Q1 phm Maximum Product Warranty In Years
MaximumProductWarrantyInYears
P10Y
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
91389000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
79154000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
18276000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
16130000 USD
CY2020Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
243000 USD
CY2019Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
4461000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
88395000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
79747000 USD
CY2020Q1 phm Number Of Claims Under Review By Management
NumberOfClaimsUnderReviewByManagement
1000 claim
CY2020Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
719200000 USD
CY2019Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
709800000 USD
CY2020Q1 phm Incurred But Not Reported Percentage Of Liability Reserves
IncurredButNotReportedPercentageOfLiabilityReserves
0.67
CY2019Q4 phm Incurred But Not Reported Percentage Of Liability Reserves
IncurredButNotReportedPercentageOfLiabilityReserves
0.68
CY2019Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
709798000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1900000 USD
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1700000 USD
CY2020Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
1300000 USD
CY2019Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-3875000 USD
CY2020Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
10375000 USD
CY2019Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
21364000 USD
CY2020Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
719172000 USD
CY2019Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
729170000 USD
CY2019Q1 phm Writeoffofinsurancereceivables
Writeoffofinsurancereceivables
11600000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76200000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
96800000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70000000.0 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
91400000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9600000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7800000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
5900000 USD
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
5800000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
9900000 USD
CY2019Q1 us-gaap Lease Cost
LeaseCost
8800000 USD
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2200000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
13802000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
22212000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20306000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18996000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
13328000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
26508000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
115152000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18376000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
96776000 USD
CY2020Q1 phm Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
4100000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
326573000 USD
CY2020Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2020Q1 us-gaap Assets
Assets
11423374000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2094505000 USD
CY2020Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
72546000 USD
CY2020Q1 us-gaap Line Of Credit
LineOfCredit
270000000 USD
CY2020Q1 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
700000000 USD
CY2020Q1 us-gaap Notes Payable
NotesPayable
2755932000 USD
CY2019Q4 us-gaap Notes Payable
NotesPayable
2765040000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.057
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1816778000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
34475000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1851253000 USD
CY2020Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7857664000 USD
CY2020Q1 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
31636000 USD
CY2020Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
363854000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
54495000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
935532000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
178553000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
150387000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
5892983000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5530391000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11423374000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1217913000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
33543000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1251456000 USD
CY2019Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7680614000 USD
CY2019Q4 us-gaap Inventory Real Estate Held For Sale
InventoryRealEstateHeldForSale
24009000 USD
CY2019Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
508967000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
59766000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
895686000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
124992000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
170107000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2019Q4 us-gaap Assets
Assets
10715597000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2129711000 USD
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
36093000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
5257417000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5458180000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10715597000 USD
CY2020Q1 us-gaap Revenues
Revenues
2294980000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
263669000 USD
CY2020Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
20190000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2524000 USD
CY2020Q1 phm Intercompany Interest
IntercompanyInterest
0 USD
CY2020Q1 phm Income Loss Before Income Taxes And Equity In Income Loss Of Subsidiaries
IncomeLossBeforeIncomeTaxesAndEquityInIncomeLossOfSubsidiaries
263769000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
60058000 USD
CY2020Q1 phm Income Loss Before Equity In Income Loss Of Subsidiaries
IncomeLossBeforeEquityInIncomeLossOfSubsidiaries
203711000 USD
CY2020Q1 phm Equity In Income Loss Of Subsidiaries
EquityInIncomeLossOfSubsidiaries
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
203711000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
203736000 USD
CY2019Q1 us-gaap Revenues
Revenues
1996693000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
252727000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-973000 USD
CY2019Q1 phm Intercompany Interest
IntercompanyInterest
0 USD
CY2019Q1 phm Income Loss Before Income Taxes And Equity In Income Loss Of Subsidiaries
IncomeLossBeforeIncomeTaxesAndEquityInIncomeLossOfSubsidiaries
216703000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49946000 USD
CY2019Q1 phm Income Loss Before Equity In Income Loss Of Subsidiaries
IncomeLossBeforeEquityInIncomeLossOfSubsidiaries
166757000 USD
CY2019Q1 phm Equity In Income Loss Of Subsidiaries
EquityInIncomeLossOfSubsidiaries
0 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
166757000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
166782000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
204615000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20139000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
5837000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1706000 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
83200000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95796000 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-56573000 USD
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9245000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
700000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
95676000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14838000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
32740000 USD
CY2020Q1 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
490978000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
599797000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1251456000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1851253000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
158905000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16070000 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1289000 USD
CY2019Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-291000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17068000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-126273000 USD
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3605000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1445000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
24999000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10350000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
30802000 USD
CY2019Q1 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-194584000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52747000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1133700000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1080953000 USD

Files In Submission

Name View Source Status
0000822416-20-000014-index-headers.html Edgar Link pending
0000822416-20-000014-index.html Edgar Link pending
0000822416-20-000014.txt Edgar Link pending
0000822416-20-000014-xbrl.zip Edgar Link pending
exhibit31aceocertifica.htm Edgar Link pending
exhibit31bcfocertifica.htm Edgar Link pending
exhibit32-certificatio.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
phm-20200331.xsd Edgar Link pending
phm-20200331_cal.xml Edgar Link unprocessable
phm-20200331_def.xml Edgar Link unprocessable
phm-20200331_lab.xml Edgar Link unprocessable
phm-20200331_pre.xml Edgar Link unprocessable
phm331202010-q.htm Edgar Link pending
phm331202010-q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending